NovaBay Pharmaceuticals (NBY) Institutional Ownership → Biden out June 13; Kamala won’t replace him? (From Paradigm Press) (Ad) Free NBY Stock Alerts $0.09 0.00 (0.00%) (As of 05/2/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsOwnershipSEC FilingsSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsOwnershipSEC FilingsSocial Media Institutional Ownership Changes (13F Filings) for NovaBay Pharmaceuticals (NYSE:NBY)CurrentInstitutional OwnershipPercentage23.25%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$146.63KNumber ofInstitutional Sellers(last 12 months)0 Get NBY Insider Trade Alerts Want to know when executives and insiders are buying or selling NovaBay Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad Paradigm PressBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report NovaBay Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2024Armistice Capital LLC718,768$147K0.0%N/A11.007% (Data available from 1/1/2016 forward) NBY Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NBY shares? During the previous two years, the following institutional investors and hedge funds held shares of NovaBay Pharmaceuticals shares: Armistice Capital LLC ($147K).Learn more on NBY's institutional investors. What percentage of NovaBay Pharmaceuticals stock is owned by institutional investors? 23.25% of NovaBay Pharmaceuticals stock is owned by institutional investors. Learn more on NBY's institutional investor holdings. Which institutional investors have been buying NovaBay Pharmaceuticals stock? The following institutional investors have purchased NovaBay Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($718.77K). How much institutional buying is happening at NovaBay Pharmaceuticals? Institutional investors have bought a total of 718,768 shares in the last 24 months. This purchase volume represents approximately $146.63K in transactions. Related Companies: CLVR Major Shareholders AGRX Major Shareholders ARAV Major Shareholders SXTP Major Shareholders ALLR Major Shareholders PHIO Major Shareholders VRPX Major Shareholders CWBR Major Shareholders CYTO Major Shareholders MBIO Major Shareholders This page (NYSE:NBY) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressUrgent Nvidia WarningAltimetryYour bank is lying to you.MyBankTrackerThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingTrump just won 2024Porter & CompanyHe Is Giving Away BitcoinCrypto Swap Profits4 coins to be the “Next Bitcoin”True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NovaBay Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.